1. Liquiritigenin protects against myocardial ischemic by inhibiting oxidative stress, apoptosis, and L‐type Ca 2+ channels
   Muqing Zhang et al, 2022, Phytotherapy Research CrossRef
2. To Explore the Key Active Compounds and Therapeutic Mechanism of Guizhi Gancao Decoction in Coronary Heart Disease by Network Pharmacology and Molecular Docking
   Hua-jing Yuan et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
3. Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway
   Chunjun Li et al, 2023, Front. Pharmacol. CrossRef
4. Liquiritigenin Attenuated Collagen-Induced Arthritis and Cardiac Complication via Inflammation and Fibrosis Inhibition in Mice
   Xiaoran Ning et al, 2023, Chem. Pharm. Bull. CrossRef
5. Differential compounds of licorice before and after honey roasted and anti-arrhythmia mechanism via LC-MS/MS and network pharmacology analysis
   Lujie Lu et al, 2023, Journal of Liquid Chromatography & Related Technologies CrossRef
6. Liquiritigenin regulates insulin sensitivity and ameliorates inflammatory responses in the nonalcoholic fatty liver by activation PI3K/AKT pathway
   Lei Bao et al, 2023, Chem Biol Drug Des CrossRef
7. Jakyak-gamcho-tang, a decoction of Paeoniae Radix and Glycyrrhizae Radix et Rhizoma, ameliorates dexamethasone-induced muscle atrophy and muscle dysfunction
   Aeyung Kim et al, 2024, Phytomedicine CrossRef
8. Melatonin enhances captopril mediated cardioprotective effects and improves mitochondrial dynamics in male Wistar rats with chronic heart failure
   Sherein F. El-Sayed et al, 2024, Sci Rep CrossRef
9. Canagliflozin combined with aerobic exercise protects against chronic heart failure in rats
   Helin Sun et al, 2024, iScience CrossRef
10. Targeting MAPK-ERK/JNK pathway: A potential intervention mechanism of myocardial fibrosis in heart failure
    Zeyu Zhang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
11. Interpreting the Mechanism of Active Ingredients in Polygonati Rhizoma in Treating Depression by Combining Systemic Pharmacology and In Vitro Experiments
    Xin Wei et al, 2024, Nutrients CrossRef
12. Research Progress of Traditional Chinese Medicine Based on TGF-β/Smad Signal Pathway in Preventing and Treating Myocardial Fibrosis in Heart Failure
    Ximei Zhu et al, 2024, JCMP CrossRef
13. Polygonatum sibiricum component liquiritigenin restrains breast cancer cell invasion and migration by inhibiting HSP90 and chaperone-mediated autophagy
    Suli Xu et al, 2024, Korean J Physiol Pharmacol CrossRef
14. Cardioprotective Effects of Palmitoleic Acid (C16:1n7) in a Mouse Model of Catecholamine-Induced Cardiac Damage Are Mediated by PPAR Activation.
    Iris Rosa Betz et al, 2021, Int J Mol Sci CrossRef
15. Prospects for the Use of Cell Cultures in Modeling Myocardial Diseases: Hypertrophic Cardiomyopathy
    A. L. Klass et al, 2024, Cell Tiss. Biol. CrossRef
16. Application of Compounds with Anti‐Cardiac Fibrosis Activity: A Review
    Yu‐Qing Meng et al, 2024, Chemistry & Biodiversity CrossRef
17. Liquiritigenin ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function, reducing endoplasmic reticulum stress and modulating gut microbiota
    Luyao Liu et al, 2024, Journal of Functional Foods CrossRef
18. The Multifaceted Anti-Atherosclerotic Properties of Herbal Flavonoids: A Comprehensive Review
    Meiwen Huang et al, 2024, Pharmacological Research CrossRef
19. Isoproterenol mechanisms in inducing myocardial fibrosis and its application as an experimental model for the evaluation of therapeutic potential of phytochemicals and pharmaceuticals
    Lujain Bader Eddin et al, 2024, Anim Models and Exp Med CrossRef